Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes
Loading...
Date
Author(s)
Editor(s)
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
To determine the impact of galectin-3 levels on the progression of metabolic disorders
and structural-functional changes in the myocardium and blood vessels in patients with
concomitant systemic arterial hypertension (AH) and type 2 diabetes mellitus (type 2 DM).
Description
Citation
Bobronnikova L. R. Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes / L. R. Bobronnikova // Vessel Plus. – 2017. – № 1. – Р. 61–67. – DOI: 10.20517/2574-1209.2016.10.